Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Equillium Inc
(NQ:
EQ
)
1.160
+0.070 (+6.42%)
Streaming Delayed Price
Updated: 3:13 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Equillium Inc
< Previous
1
2
3
4
5
Next >
Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates
August 15, 2022
From
Equillium, Inc.
Via
Business Wire
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
August 08, 2022
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...
Via
Benzinga
Equillium Announces Presentation at the 3rd Annual Cytokine-Based Drug Development Summit
July 28, 2022
From
Equillium, Inc.
Via
Business Wire
89 Biggest Movers From Friday
June 21, 2022
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 15, 2022
Via
Benzinga
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
June 14, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
May 27, 2022
During Friday's session, 59 stocks hit new 52-week lows.
Via
Benzinga
Equillium to Present at Two Upcoming Investor Conferences
May 17, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
May 12, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Publication of Abstract for the Annual Congress of the European Hematology Association
May 12, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Three Poster Presentations at the Annual Meeting of The American Association of Immunologists
May 09, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Three Poster Presentations at the Transplantation & Cellular Meetings of the ASTCT and CIBMTR
April 25, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Oral Presentation at the Italian Society of Experimental Hematology
April 04, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates
March 23, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Two Oral Presentations at the Annual Meeting of the European Society for Blood and Marrow Transplantation
March 23, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium's Itolizumab Shows Durable Clinical Response In GvHD Patients
March 23, 2022
Equillium Inc (NASDAQ: EQ) announced two oral presentations on itolizumab at the Annual Meeting of the European Society for Blood and Marrow Transplantation.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 17, 2022
Thursday saw 34 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: SecureWorks (NASDAQ:SCWX) was the largest company by market cap to...
Via
Benzinga
Equillium Adds Three Drugs To Its Pipeline Via Bioniz Acquisition
February 16, 2022
Equillium Inc (NASDAQ: EQ), with only one asset in its pipeline, is expanding its drug development efforts via the acquisition of Bioniz Therapeutics. The deal,...
Via
Benzinga
Equillium Acquires Bioniz Therapeutics Significantly Expanding Pipeline of Novel Immunomodulatory Drug Candidates
February 16, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium Provides Timing Update on Conference Presentations
February 15, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium to Present at the SVB Leerink Virtual Global Healthcare Conference
February 09, 2022
From
Equillium, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
January 21, 2022
Gainers Mustang Bio (NASDAQ:MBIO) shares ...
Via
Benzinga
Equillium Announces Multiple Abstracts Accepted for Presentation at the Transplantation & Cellular Meetings of ASTCT and CIBMTR
January 10, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium to Present at the H.C. Wainwright Virtual BioConnect Conference
January 05, 2022
From
Equillium, Inc.
Via
Business Wire
10 Biggest Price Target Changes For Wednesday
January 05, 2022
UBS cut the price target for Adobe Inc. (NASDAQ: ADBE) from $635 to $575. Adobe shares fell 2.3% to $541.06 in pre-market trading. SVB Leerink lowered the price target on...
Via
Benzinga
45 Biggest Movers From Yesterday
January 05, 2022
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...
Via
Benzinga
Equillium Announces Publication of Data in the Journal of Clinical Investigation Highlighting the Importance of the CD6-ALCAM Pathway in the Pathogenesis of Lupus Nephritis
January 04, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium To Reassess Potential For Its Asthma Trials
January 04, 2022
Equillium Inc's (NASDAQ: EQ) Phase 1b EQUIP study of itolizumab in patients with uncontrolled asthma met its primary objective. The data demonstrated an on-target...
Via
Benzinga
Equillium Announces Data from Phase 1b EQUIP Study in Patients with Uncontrolled Asthma
January 04, 2022
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Additional Patient Data at ASH 2021 Demonstrating Continued Positive and Durable Clinical Responses in Acute Graft-Versus-Host Disease Patients Treated with Itolizumab
December 13, 2021
From
Equillium, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.